Kinetic Characterization of Factor Xa Binding Using a Quenched Fluorescent Substrate Based on the Reactive Site of Factor Xa Inhibitor from Bauhinia ungulata Seeds

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|13|1085-1093

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.13, 2003-07, pp. : 1085-1093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development

By  

Current Medicinal Chemistry, Vol. 14, Iss. 23, 2007-10 ,pp. : 2471-2481

Bentham Science Publishers

Access to resources Recommend Favorite

Edoxaban: A New Oral Direct Factor Xa Inhibitor

By Camm A. John  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1503-1526

Adis International

Access to resources Recommend Favorite

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy

By Turpie Alexander GG  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1373-1384

Informa Healthcare

Access to resources Recommend Favorite

Rivaroxaban, the first oral, direct factor Xa inhibitor

By Fassiadis Nicholas  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 2945-2946

Informa Healthcare

Access to resources Recommend Favorite

Rivaroxaban, an oral direct factor Xa inhibitor

By Piccini Jonathan P   Patel Manesh R   Mahaffey Kenneth W   Fox Keith AA   Califf Robert M  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 925-937

Informa Healthcare

Access to resources Recommend Favorite